0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

Gilead Sciences: Caution After A Re-Rating Amidst New Concentration Risks [Seeking Alpha]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Seeking Alpha
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Gilead's growth is increasingly concentrated in its HIV franchise, now nearly three-quarters of product revenue, raising dependency and concentration risks. Recent M&A activity, including the $7.8B Arcellx and $1.675B Ouro deals, aims to diversify, but their impact on revenue remains uncertain. I have exited my position due to demanding valuations and lack of diversified growth, despite strong dividend payouts and manageable leverage. Looking for more investing ideas like this one? Get them exclusively at Value In Corporate Events. Learn More » Michael Vi/iStock Editorial via Getty Images Shares of Gilead Sciences ( GILD ) have been on a major run higher in recent years, far outperforming many peers that have been struggling. This made sense, as Gilead traded at very low valuations from the More on my IG service If you like to see more ideas, please subscribe to the Investing Group "Value in Corporate Events" here and try the free trial. In this service we cover major e [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Gilead Sciences: Caution After A Re-Rating Amidst New Concentration Risks [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Seeking Alpha
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Gilead's growth is increasingly concentrated in its HIV franchise, now nearly three-quarters of product revenue, raising dependency and concentration risks. Recent M&A activity, including the $7.8B Arcellx and $1.675B Ouro deals, aims to diversify, but their impact on revenue remains uncertain. I have exited my position due to demanding valuations and lack of diversified growth, despite strong dividend payouts and manageable leverage. Looking for more investing ideas like this one? Get them exclusively at Value In Corporate Events. Learn More » Michael Vi/iStock Editorial via Getty Images Shares of Gilead Sciences ( GILD ) have been on a major run higher in recent years, far outperforming many peers that have been struggling. This made sense, as Gilead traded at very low valuations from the More on my IG service If you like to see more ideas, please subscribe to the Investing Group "Value in Corporate Events" here and try the free trial. In this service we cover major e [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS